Search company, investor...

Tequesta Marine Biosciences


Incubator/Accelerator | Alive

About Tequesta Marine Biosciences

Tequesta Marine Biosciences is a specialty pharmaceutical firm that develops small molecule therepeutic drugs for inflammatory conditions.

Headquarters Location

Boca Raton, Florida, 33431,

United States

Missing: Tequesta Marine Biosciences's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Tequesta Marine Biosciences's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Tequesta Marine Biosciences Frequently Asked Questions (FAQ)

  • Where is Tequesta Marine Biosciences's headquarters?

    Tequesta Marine Biosciences's headquarters is located at Boca Raton.

  • What is Tequesta Marine Biosciences's latest funding round?

    Tequesta Marine Biosciences's latest funding round is Incubator/Accelerator.

  • Who are the investors of Tequesta Marine Biosciences?

    Investors of Tequesta Marine Biosciences include Enterprise Development Corporation of South Florida.

  • Who are Tequesta Marine Biosciences's competitors?

    Competitors of Tequesta Marine Biosciences include Novira Therapeutics, Scynexis, SkinMedica, Surface Logix, ZARS and 12 more.

Compare Tequesta Marine Biosciences to Competitors

Sirion Holdings

Sirion Holdings is a specialty pharmaceutical company focused on ophthamology drugs


Ameritox is the nation's leader in pain prescription monitoring.


Axcan is a specialty pharmaceutical company focused on the development and commercialization of drugs for diseases involving the digestive system.


Oxagen is a biopharmaceutical company that develops small molecule drugs for inflammatory and respiratory diseases.

Ikano Therapeutics

Ikano Therapeutics is a specialty pharmaceutical company focused on developing nasally delivered pharmaceutical products with a particular focus on drugs treating pain and disorders related to the central nervous system.

Christaens International

Nycomed is a privately owned global pharmaceutical company with a differentiated portfolio focused on branded medicines in gastroenterology, respiratory diseases, inflammation diseases, pain, osteoporosis and tissue management. nnIts R&D is built to be open for partnerships also beyond its core areas in inflammatory, respiratory diseases and pain as in-licensing is a cornerstone in the company's growth strategy.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.